Back to Search
Start Over
Soluble CD30 as a predictor of kidney graft outcome.
- Source :
-
Transplantation [Transplantation] 2002 Jan 15; Vol. 73 (1), pp. 3-6. - Publication Year :
- 2002
-
Abstract
- Background: In the present study, we investigated whether the soluble form of CD30 (sCD30), a marker for T helper 2-type cytokine-producing T cells, is increased in sera of potential kidney graft recipients. We also investigated whether the pretransplantation serum sCD30 content is related to kidney graft survival.<br />Methods: Pretransplantation sera of 844 cadaver kidney recipients from three transplant centers in Germany were tested for serum sCD30 content using a commercially available ELISA kit.<br />Results: Kidney graft recipients showed a significantly higher serum sCD30 content than healthy controls (P<0.0001). High sCD30 serum content was associated with graft rejection. The 2-year graft survival rate in recipients with a high pretransplantation serum sCD30 was 68+/-6%, significantly lower than the 86+/-1% rate in recipients with a low sCD30 (P<0.0001). Importantly, high sCD30 was indicative of an increased risk of graft loss even in recipients without lymphocytotoxic alloantibodies.<br />Conclusion: These data show that an elevated pretransplantation serum sCD30 reflects an immune state that is detrimental for kidney graft survival.
- Subjects :
- Adult
Cadaver
Female
Graft Survival immunology
Histocompatibility Testing
Humans
Immunosuppressive Agents therapeutic use
Kidney Transplantation immunology
Male
Reference Values
Reoperation
T-Lymphocytes, Cytotoxic immunology
Time Factors
Tissue Donors
Biomarkers blood
Graft Survival physiology
Ki-1 Antigen blood
Kidney Transplantation physiology
Th2 Cells immunology
Subjects
Details
- Language :
- English
- ISSN :
- 0041-1337
- Volume :
- 73
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Transplantation
- Publication Type :
- Academic Journal
- Accession number :
- 11792970
- Full Text :
- https://doi.org/10.1097/00007890-200201150-00002